Semmax Financial Advisors Inc. Bristol Myers Squibb CO Transaction History
Semmax Financial Advisors Inc.
- $320 Million
- Q2 2024
A detailed history of Semmax Financial Advisors Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 89 shares of BMY stock, worth $4,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89
Previous 88
1.14%
Holding current value
$4,733
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,428Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.86 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...